The fourth-quarter 2024 earnings cycle is here, with quite a few healthcare companies having reported results. Early reports ...

European shares were at a record high on Friday, led by technology and healthcare stocks, even as caution prevailed ahead of ...

DeepSeek's AI model causes tech stocks to drop, but healthcare tech ETFs benefit from advancements in AI without vulnerability to market volatility.

These healthcare REITs are rated Buy at Jefferies and make sense now for investors seeking dependable passive income and a ...

Fresenius Medical Care has seen 18.5% growth, with strong prospects. Learn why FMS stock’s fair value of $34/share makes it a ...

The final move, made by Larry Culp, was to break GE into three businesses: GE Verona, GE Healthcare , and GE Aerospace. The ...

After posting a fresh all-time high in the previous session, the TSX Composite Index remains on track to post its third consecutive weekly gain.

Summers Value Partners, an investment management company, released its fourth quarter 2024 investor letter. A copy of the ...

Vertex Pharmaceuticals (VRTX – Research Report) received a Buy rating and a $480.00 price target from Cantor Fitzgerald analyst Olivia Brayer ...

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET ...

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Weight-loss drugs are transforming health care and Wall Street, but exciting prospects don’t necessarily mean a company is a good investment.